Related Experiment Videos
Initial Impression of Two New Brief-Pulse Electroconvulsive Therapy Machines.
Stephani M. Nilsen1, Kenneth W. Willis, Helen M. Pettinati
1Carrier Foundation, Belle Mead, Piscataway, New Jersey, USA.
Convulsive Therapy
|January 1, 1986
Summary
A new brief-pulse electroconvulsive therapy (ECT) device, the Thymatron, offers U.S. patients their first choice in brief-pulse equipment. This study compares its features, safety, practicality, and cost against a MECTA SR-1 model.
Area of Science:
- Neurology
- Biomedical Engineering
- Psychiatry
Background:
- Historically, only two U.S. manufacturers produced electroconvulsive therapy (ECT) machines.
- These machines featured distinct waveforms: a sine-wave (Medcraft Corp.) and a brief-pulse bidirectional square-wave (MECTA Corp.).
Purpose of the Study:
- To introduce and compare the new Thymatron brief-pulse device with a MECTA SR-1 model.
- To evaluate features, safety, practicality, and cost of available brief-pulse electroconvulsive therapy (ECT) equipment.
Main Methods:
- Comparative analysis of electroconvulsive therapy (ECT) devices.
- Initial impressions based on features, safety, practicality, and cost.
Main Results:
- The Thymatron's market entry in 1985 provided the first choice in brief-pulse electroconvulsive therapy (ECT) equipment in the U.S.
- The study offers initial impressions on the Thymatron and MECTA SR-1 brief-pulse models.
Conclusions:
- The availability of multiple brief-pulse electroconvulsive therapy (ECT) devices enhances options for U.S. healthcare providers.
- Further evaluation is needed to fully understand the clinical implications of these brief-pulse electroconvulsive therapy (ECT) devices.